Literature DB >> 11688967

Downregulation of urokinase-type plasminogen activator receptor (uPAR) induces caspase-mediated cell death in human glioblastoma cells.

N Yanamandra1, S D Konduri, S Mohanam, D H Dinh, W C Olivero, M Gujrati, G L Nicolson, M Obeyeseke, J S Rao.   

Abstract

Urokinase-type plasminogen activator receptors (uPARs) play an important role in tumor invasion by localizing degradative enzymes at the invasive zone. Our previous studies with human glioblastoma cell line SNB19 expressing AS-uPAR stable tranfectant lose their invasive properties when injected in vivo. The aim of the present study is to investigate whether the inhibition of tumor formation is due to apoptosis. Apoptosis is a highly conserved cell suicide program essential for development and tissue homeostasis of all metazoan organisms. Key to the apoptotic program is a family of cystein proteases termed caspases, which are important for execution of apoptosis by cleavage of essential cellular proteins. We found loss of mitochondrial transmembrane potential, release of cytochrome C from mitochondria and subsequent activation of Caspase-9 in SNB 19 AS-uPAR cells compared to parental and vector controls. Our results indicate that suppression of uPAR results in apoptosis and suggest that Caspase-9 dependent apoptosis plays an important role in SNB19 AS-uPAR-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11688967     DOI: 10.1023/a:1011941114862

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  28 in total

Review 1.  The mitochondrial permeability transition.

Authors:  M Zoratti; I Szabò
Journal:  Biochim Biophys Acta       Date:  1995-07-17

Review 2.  Mitochondria and apoptosis.

Authors:  D R Green; J C Reed
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

Review 3.  Cell death in development.

Authors:  D L Vaux; S J Korsmeyer
Journal:  Cell       Date:  1999-01-22       Impact factor: 41.582

4.  Inhibition of in vivo tumorigenicity and invasiveness of a human glioblastoma cell line transfected with antisense uPAR vectors.

Authors:  Y Go; S K Chintala; S Mohanam; Z Gokaslan; B Venkaiah; R Bjerkvig; K Oka; G L Nicolson; R Sawaya; J S Rao
Journal:  Clin Exp Metastasis       Date:  1997-07       Impact factor: 5.150

5.  Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade.

Authors:  P Li; D Nijhawan; I Budihardjo; S M Srinivasula; M Ahmad; E S Alnemri; X Wang
Journal:  Cell       Date:  1997-11-14       Impact factor: 41.582

Review 6.  Emerging roles of caspase-3 in apoptosis.

Authors:  A G Porter; R U Jänicke
Journal:  Cell Death Differ       Date:  1999-02       Impact factor: 15.828

7.  Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody.

Authors:  S Mohanam; R Sawaya; I McCutcheon; F Ali-Osman; D Boyd; J S Rao
Journal:  Cancer Res       Date:  1993-09-15       Impact factor: 12.701

8.  In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis.

Authors:  E Bacharach; A Itin; E Keshet
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

9.  The Caenorhabditis elegans genes ced-3 and ced-4 act cell autonomously to cause programmed cell death.

Authors:  J Y Yuan; H R Horvitz
Journal:  Dev Biol       Date:  1990-03       Impact factor: 3.582

10.  Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death.

Authors:  N Zamzami; P Marchetti; M Castedo; D Decaudin; A Macho; T Hirsch; S A Susin; P X Petit; B Mignotte; G Kroemer
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

View more
  10 in total

1.  Regulation of urokinase receptor expression by p53: novel role in stabilization of uPAR mRNA.

Authors:  Sreerama Shetty; Thirunavukkarasu Velusamy; Steven Idell; Praveenkumar Shetty; Andrew P Mazar; Yashodhar P Bhandary; Rashmi S Shetty
Journal:  Mol Cell Biol       Date:  2007-06-04       Impact factor: 4.272

2.  Urokinase receptor orchestrates the plasminogen system in airway epithelial cell function.

Authors:  Ceri E Stewart; Ian Sayers
Journal:  Lung       Date:  2013-02-14       Impact factor: 2.584

3.  Development of novel therapeutics targeting the urokinase plasminogen activator receptor (uPAR) and their translation toward the clinic.

Authors:  Andrew P Mazar; Richard W Ahn; Thomas V O'Halloran
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

4.  Simultaneous downregulation of uPAR and MMP-9 induces overexpression of the FADD-associated protein RIP and activates caspase 9-mediated apoptosis in gliomas.

Authors:  Christopher S Gondi; Dzung H Dinh; Meena Gujrati; Jasti S Rao
Journal:  Int J Oncol       Date:  2008-10       Impact factor: 5.650

5.  Triterpenoids from Glycine max decrease invasiveness and induce caspase-mediated cell death in human SNB19 glioma cells.

Authors:  Niranjan Yanamandra; Mark A Berhow; Santhi Konduri; Dzung H Dinh; William C Olivero; Garth L Nicolson; Jasti S Rao
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

6.  Regulation of plasminogen activator inhibitor-1 expression by tumor suppressor protein p53.

Authors:  Sreerama Shetty; Praveenkumar Shetty; Steven Idell; Thirunavukkarasu Velusamy; Yashodhar P Bhandary; Rashmi S Shetty
Journal:  J Biol Chem       Date:  2008-05-09       Impact factor: 5.157

7.  Urokinase expression by tumor suppressor protein p53: a novel role in mRNA turnover.

Authors:  Praveenkumar Shetty; Thirunavukkarasu Velusamy; Yashodhar P Bhandary; Rashmi S Shetty; Ming-Cheh Liu; Sreerama Shetty
Journal:  Am J Respir Cell Mol Biol       Date:  2008-04-03       Impact factor: 6.914

8.  Down-regulation of uPAR and uPA activates caspase-mediated apoptosis and inhibits the PI3K/AKT pathway.

Authors:  Christopher S Gondi; Neelima Kandhukuri; Dzung H Dinh; Meena Gujrati; Jasti S Rao
Journal:  Int J Oncol       Date:  2007-07       Impact factor: 5.650

9.  Activators and inhibitors of the plasminogen system in Alzheimer's disease.

Authors:  Rachel Barker; Patrick G Kehoe; Seth Love
Journal:  J Cell Mol Med       Date:  2012-04       Impact factor: 5.310

Review 10.  Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer.

Authors:  Bing-Tao Zhai; Huan Tian; Jing Sun; Jun-Bo Zou; Xiao-Fei Zhang; Jiang-Xue Cheng; Ya-Jun Shi; Yu Fan; Dong-Yan Guo
Journal:  J Transl Med       Date:  2022-03-18       Impact factor: 5.531

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.